Merck | MRK - Ebit

Preço das Ações
109.14
Mudança Diária
-1.81 -1.63%
Mensal
-9.27%
Anual
31.08%
Q2 Previsão
109.51




Ebit Alterar Data
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 684M 2026-03
ALKERMES USD -10.95M 100.03M 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 502.8M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 16.37B 3.5B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
J&J USD 6.62B 1.51B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Novo Nordisk DKK 32.38B 1.7B 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 3.74B 2.23B 2025-09
United Therapeutics USD -14.6M 403.9M 2025-12
Zoetis USD 835M 140M 2025-12